Wedbush Sees Huge Upside On Xos
Wedbush analyst Daniel Ives initiated Xos Inc (NASDAQ:XOS) with an Outperform rating and a price target of $10, implying an upside of 113%.…
48 Biggest Movers From Friday
Gainers
ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday.
34 Stocks Moving In Friday’s Mid-Day Session
Gainers
ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares jumped 76.2% to $6.08.
Xos Files Form 8-K Upon Closing Of Business Combination With NextGen Acquisition
Xos, Inc (NASDAQ:XOS) began trading on the Nasdaq on August 20, 2021, after completing a merger with NextGen Acquisition Corp. The…
DA Davidson Maintains Buy on Xos, Lowers Price Target to $15
DA Davidson analyst Michael Shlisky maintains Xos (NASDAQ:XOS) with a Buy and lowers the price target from $19 to $15.
